Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

KZR

Kezar Life Sciences (KZR)

Kezar Life Sciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:KZR
FechaHoraFuenteTítuloSímboloCompañía
06/03/202516:46Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:KZRKezar Life Sciences Inc
05/03/202519:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KZRKezar Life Sciences Inc
03/03/202515:01Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:KZRKezar Life Sciences Inc
27/02/202515:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KZRKezar Life Sciences Inc
18/02/202515:01Business WireKezar Life Sciences to Present at Virtual KOL Event Hosted by William Blair on Zetomipzomib Clinical Development in Autoimmune Hepatitis and Provide a Safety Update from the PALIZADE Trial for Lupus Nephritis on February 27, 2025NASDAQ:KZRKezar Life Sciences Inc
14/02/202509:42Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:KZRKezar Life Sciences Inc
10/02/202523:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:KZRKezar Life Sciences Inc
05/02/202516:19Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:KZRKezar Life Sciences Inc
12/11/202415:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KZRKezar Life Sciences Inc
12/11/202415:01Business WireKezar Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:KZRKezar Life Sciences Inc
29/10/202416:05Edgar (US Regulatory)Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]NASDAQ:KZRKezar Life Sciences Inc
28/10/202407:30Business WireKezar Life Sciences Announces 1-for-10 Reverse Stock SplitNASDAQ:KZRKezar Life Sciences Inc
17/10/202408:22Edgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]NASDAQ:KZRKezar Life Sciences Inc
17/10/202407:35Business WireKezar Board Unanimously Rejects Unsolicited Concentra Proposal and Adopts Limited Duration Stockholder Rights PlanNASDAQ:KZRKezar Life Sciences Inc
17/10/202407:30Business WireKezar Life Sciences Announces Positive IDMC Safety Review of PORTOLA Trial of Zetomipzomib in Patients with Autoimmune Hepatitis and Provides PALIZADE UpdateNASDAQ:KZRKezar Life Sciences Inc
10/10/202407:30Business WireKezar Confirms Receipt of Unsolicited, Non-Binding Acquisition ProposalNASDAQ:KZRKezar Life Sciences Inc
04/10/202416:00Business WireKezar Life Sciences Announces Clinical Hold of Zetomipzomib IND for Treatment of Lupus NephritisNASDAQ:KZRKezar Life Sciences Inc
30/09/202407:30Business WireKezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis PatientsNASDAQ:KZRKezar Life Sciences Inc
04/09/202415:01Business WireKezar Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:KZRKezar Life Sciences Inc
13/08/202415:02Business WireKezar Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:KZRKezar Life Sciences Inc
10/07/202415:01Business WireKezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:KZRKezar Life Sciences Inc
29/05/202415:01Business WireKezar Life Sciences to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:KZRKezar Life Sciences Inc
09/05/202415:01Business WireKezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:KZRKezar Life Sciences Inc
06/05/202415:05Business WireKezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:KZRKezar Life Sciences Inc
14/03/202415:01Business WireKezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business UpdateNASDAQ:KZRKezar Life Sciences Inc
28/02/202415:01Business WireKezar Life Sciences to Participate in the TD Cowen 44th Annual Health Care ConferenceNASDAQ:KZRKezar Life Sciences Inc
26/02/202417:30Business WireEverest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus NephritisNASDAQ:KZRKezar Life Sciences Inc
14/02/202405:50Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:KZRKezar Life Sciences Inc
17/01/202416:09Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KZRKezar Life Sciences Inc
21/11/202315:01Business WireKezar Life Sciences to Present at the 6th Annual Evercore ISI HealthCONx ConferenceNASDAQ:KZRKezar Life Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:KZR

Su Consulta Reciente

Delayed Upgrade Clock